Zeteo Biomedical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Zeteo Biomedical is a private, specialized drug delivery technology company offering platform-based solutions for combination products. Its core offerings are the ZTECH-L™ (liquid) and ZTECH-P™ (powder) delivery platforms, which are designed for ophthalmic, intranasal, sublingual, and other local routes. The company operates across the development lifecycle, providing analytical, pre-commercial, and commercial services to partners, with a noted focus on biosecurity applications like rapid vaccine deployment.

Infectious DiseaseOphthalmicCNS Disorders

Technology Platform

ZTECH-L™ for liquid formulations and ZTECH-P™ for powder/reconstituted powder formulations. Platforms feature no-priming design, precise dosing, unit-dose packaging, dose counters, and scalable Form Fill Seal technology for multiple routes of administration (ophthalmic, intranasal, sublingual, etc.).

Opportunities

Growing demand for patient-centric, non-invasive drug delivery systems, especially for biologics and vaccines.

Significant opportunity in the biosecurity and public health sector for rapid deployment of intranasal/sublingual vaccines and countermeasures.

The platform-as-a-service model allows for recurring revenue across the drug development lifecycle.

Risk Factors

High dependency on securing partnerships with pharmaceutical companies in a competitive drug delivery technology landscape.

Regulatory risk as a component of combination products, where device performance can impact drug approval.

Limited public information on financial backing and commercial traction raises questions about scalability and market execution.

Competitive Landscape

Competes with large, established drug delivery device companies (e.g., Aptar Pharma, Nemera, Gerresheimer) and numerous specialized startups. Differentiation is claimed through integrated platform solutions, a focus on multiple local delivery routes, and biosecurity applications. Success depends on technological performance, cost-effectiveness, and forming strategic alliances.

More companies in Drug Delivery & Formulation →More companies in United States →